Microba

MAP.AX

Tags: AU Healthcare Medical - Diagnostics & Research

Microba Life Sciences Limited Price (MAP.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

409,858,784

(23.0844)%

Market Cap of Microba (MAP.AX)

Market cap:

As of , MAP.AX has a market cap of . This makes MAP.AX the 543th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; Databank, for discovery of therapeutic leads, consumer health innovations, and diagnostic biomarkers; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, can... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.145-0.325
Market Cap 89.57M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Dr. Luke Reid
IPO Date: April, 05, 2022
Country: AU
Currency: AUD
Headquaters: Brisbane, QLD
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: